美国 · SEC FORM 4
INTEGRA LIFESCIENCES HOLDINGS CORP
IART · Nasdaq · CIK 0000917520 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
6 同一窗口内观察到的 Form 4 交易行
0 sales · 6 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-05 · GRAVES JEFFREY A.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,266,960
- 上期报告
- 6,806,086
- 日均成交量
- 967,947
- 回补天数
- 7.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-11-05 | GRAVES JEFFREY A | 买入 (P) | Common Stock | 9,000 | USD 11.35 | USD 102,150 | SEC 申报 ↗ |
| 2024-05-23 | ESSIG STUART | 买入 (P) | Common Stock | 52,641 | USD 28.49 | USD 1,499,742 | SEC 申报 ↗ |
| 2024-05-21 | HILL BARBARA B | 买入 (P) | Common Stock | 36,350 | USD 27.40 | USD 995,990 | SEC 申报 ↗ |
| 2023-06-01 | Schwartz Eric | 买入 (P) | Common Stock | 2,640 | USD 37.89 | USD 100,030 | SEC 申报 ↗ |
| 2023-06-01 | De Witte Jan | 买入 (P) | Common Stock | 7,792 | USD 38.50 | USD 299,992 | SEC 申报 ↗ |
Form 4 申报证据
24 transaction lines in the latest 365-day window; 586 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Veillon-Berteloot Chantal | 代扣税 (F) | Common Stock | 1,455 | USD 16.62 | USD 24,182 | SEC 申报 ↗ |
| 2026-07-03 | Knight Lea Daniels | 代扣税 (F) | Common Stock | 5,226 | USD 18.05 | USD 94,329 | SEC 申报 ↗ |
| 2026-07-01 | Mosebrook Jeffrey | 代扣税 (F) | Common Stock | 937 | USD 17.89 | USD 16,763 | SEC 申报 ↗ |
展开近期 Form 4 证据 (20 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Veillon-Berteloot Chantal | 代扣税 (F) | Common Stock | 1,455 | USD 16.62 | USD 24,182 | SEC 申报 ↗ |
| 2026-07-03 | Knight Lea Daniels | 代扣税 (F) | Common Stock | 5,226 | USD 18.05 | USD 94,329 | SEC 申报 ↗ |
| 2026-07-01 | Mosebrook Jeffrey | 代扣税 (F) | Common Stock | 937 | USD 17.89 | USD 16,763 | SEC 申报 ↗ |
| 2026-05-09 | BRADLEY KEITH | 代扣税 (F) | Common Stock | 882 | USD 13.92 | USD 12,277 | SEC 申报 ↗ |
| 2026-05-07 | HILL BARBARA B | 奖励／授予 (A) | Common Stock | 24,338 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-11 | Veillon-Berteloot Chantal | 代扣税 (F) | Common Stock | 5,420 | USD 9.61 | USD 52,086 | SEC 申报 ↗ |
| 2026-03-11 | Singh Harvinder | 期权行权／转换 (M) | Common Stock | 18,922 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-11 | Singh Harvinder | 代扣税 (F) | Common Stock | 6,051 | USD 9.61 | USD 58,150 | SEC 申报 ↗ |
| 2026-03-11 | Mosebrook Jeffrey | 代扣税 (F) | Common Stock | 806 | USD 9.61 | USD 7,746 | SEC 申报 ↗ |
| 2026-03-11 | McBreen Michael J. | 代扣税 (F) | Common Stock | 7,247 | USD 9.61 | USD 69,644 | SEC 申报 ↗ |
| 2026-03-11 | Knight Lea Daniels | 代扣税 (F) | Common Stock | 8,089 | USD 9.61 | USD 77,735 | SEC 申报 ↗ |
| 2026-03-11 | DAVIS ROBERT T. JR. | 代扣税 (F) | Common Stock | 8,487 | USD 9.61 | USD 81,560 | SEC 申报 ↗ |
| 2026-03-10 | Singh Harvinder | 期权行权／转换 (M) | Common Stock | 1,216 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | Singh Harvinder | 代扣税 (F) | Common Stock | 601 | USD 9.55 | USD 5,740 | SEC 申报 ↗ |
| 2026-03-10 | Mosebrook Jeffrey | 代扣税 (F) | Common Stock | 341 | USD 9.55 | USD 3,257 | SEC 申报 ↗ |
| 2026-03-10 | McBreen Michael J. | 代扣税 (F) | Common Stock | 2,354 | USD 9.55 | USD 22,481 | SEC 申报 ↗ |
| 2026-03-10 | DAVIS ROBERT T. JR. | 代扣税 (F) | Common Stock | 687 | USD 9.55 | USD 6,561 | SEC 申报 ↗ |
| 2026-01-06 | Poul Mojdeh | 期权行权／转换 (M) | Common Stock | 1,390 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-06 | Poul Mojdeh | 代扣税 (F) | Common Stock | 1,390 | USD 13.13 | USD 18,251 | SEC 申报 ↗ |
| 2025-11-05 | GRAVES JEFFREY A | 买入 (P) | Common Stock | 9,000 | USD 11.35 | USD 102,150 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | IART |
| CIK | 0000917520 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 586 transaction lines from 2020-02-13 to 2026-09-01 5 P purchase lines · 76 S sale lines · 505 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.